{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-066056","form_type":"8-K","ticker":"HAE","cik":"0000313143","company_name":"HAEMONETICS CORP","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.516349+00:00","generated_at":"2026-06-01T07:49:03.134250+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Haemonetics issues $700M in 2.50% convertible notes due 2029; used to repurchase 2026 notes and repay revolver","bullets":["Issued $700M (incl. $100M greenshoe) of 2.50% Convertible Senior Notes due June 1, 2029.","Used proceeds to repurchase $200M of 0% 2026 notes for $185.5M and repay $230M revolver balance.","Entered capped call transactions costing ~$88.2M with cap price $180.18 (100% premium over stock).","Initial conversion rate 8.5385 shares/$1,000 (~$117.12/share); notes redeemable from June 2027 if stock exceeds 130% of conversion price."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-066056","json":"https://secwatch.observer/filing/0001104659-24-066056.json","markdown":"https://secwatch.observer/filing/0001104659-24-066056.md","text":"https://secwatch.observer/filing/0001104659-24-066056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313143/000110465924066056/0001104659-24-066056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313143/000110465924066056/tm2415643d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:49:03.134250+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}